Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8YWW

The structure of HKU1-B S protein with bsAb1

Summary for 8YWW
Entry DOI10.2210/pdb8yww/pdb
EMDB information39645
DescriptorSpike glycoprotein, H4B6 heavy chain, H4B6 light chain, ... (4 entities in total)
Functional Keywordssars-cov-2, antibody, viral protein/immune system, viral protein-immune system complex
Biological sourceSevere acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2)
More
Total number of polymer chains8
Total formula weight521542.63
Authors
Xia, L.Y.,Zhang, Y.Y.,Zhou, Q. (deposition date: 2024-04-01, release date: 2024-07-31, Last modification date: 2024-10-16)
Primary citationSun, H.,Xia, L.,Li, J.,Zhang, Y.,Zhang, G.,Huang, P.,Wang, X.,Cui, Y.,Fang, T.,Fan, P.,Zhou, Q.,Chi, X.,Yu, C.
A novel bispecific antibody targeting two overlapping epitopes in RBD improves neutralizing potency and breadth against SARS-CoV-2.
Emerg Microbes Infect, 13:2373307-2373307, 2024
Cited by
PubMed Abstract: SARS-CoV-2 has been evolving into a large number of variants, including the highly pathogenic Delta variant, and the currently prevalent Omicron subvariants with extensive evasion capability, which raises an urgent need to develop new broad-spectrum neutralizing antibodies. Herein, we engineer two IgG-(scFv) form bispecific antibodies with overlapping epitopes (bsAb1) or non-overlapping epitopes (bsAb2). Both bsAbs are significantly superior to the parental monoclonal antibodies in terms of their antigen-binding and virus-neutralizing activities against all tested circulating SARS-CoV-2 variants including currently dominant JN.1. The bsAb1 can efficiently neutralize all variants insensitive to parental monoclonal antibodies or the cocktail with IC lower than 20 ng/mL, even slightly better than bsAb2. Furthermore, the cryo-EM structures of bsAb1 in complex with the Omicron spike protein revealed that bsAb1 with overlapping epitopes effectively locked the S protein, which accounts for its conserved neutralization against Omicron variants. The bispecific antibody strategy engineered from overlapping epitopes provides a novel solution for dealing with viral immune evasion.
PubMed: 38953857
DOI: 10.1080/22221751.2024.2373307
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.7 Å)
Structure validation

236620

PDB entries from 2025-05-28

PDB statisticsPDBj update infoContact PDBjnumon